238 related articles for article (PubMed ID: 22159671)
41. The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in ovariectomized rats.
Zhang DW; Wang ZL; Qi W; Zhao GY
BMC Complement Altern Med; 2014 Dec; 14():484. PubMed ID: 25496560
[TBL] [Abstract][Full Text] [Related]
42. Treatment with risedronate or alendronate prevents hind-limb immobilization-induced loss of bone density and strength in adult female rats.
Mosekilde L; Thomsen JS; Mackey MS; Phipps RJ
Bone; 2000 Nov; 27(5):639-45. PubMed ID: 11062350
[TBL] [Abstract][Full Text] [Related]
43. Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat.
Andersson N; Surve VV; Lehto-Axtelius D; Ohlsson C; Håkanson R; Andersson K; Ryberg B
J Endocrinol; 2002 Dec; 175(3):695-703. PubMed ID: 12475380
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
Sakai A; Ito M; Tomomitsu T; Tsurukami H; Ikeda S; Fukuda F; Mizunuma H; Inoue T; Saito H; Nakamura T;
Osteoporos Int; 2015 Mar; 26(3):1193-202. PubMed ID: 25592133
[TBL] [Abstract][Full Text] [Related]
45. Prevention of bone loss and improvement of pain-related behavior in hind limb-unloaded mice by administration of teriparatide and bisphosphonate.
Miyamura G; Wakabayashi H; Nagao N; Kato S; Nakagawa T; Naito Y; Sudo A
Mod Rheumatol; 2021 May; 31(3):733-742. PubMed ID: 32646253
[TBL] [Abstract][Full Text] [Related]
46. Six Weeks of Daily Abaloparatide Treatment Increased Vertebral and Femoral Bone Mineral Density, Microarchitecture and Strength in Ovariectomized Osteopenic Rats.
Bahar H; Gallacher K; Downall J; Nelson CA; Shomali M; Hattersley G
Calcif Tissue Int; 2016 Nov; 99(5):489-499. PubMed ID: 27395059
[TBL] [Abstract][Full Text] [Related]
47. Lycopene treatment against loss of bone mass, microarchitecture and strength in relation to regulatory mechanisms in a postmenopausal osteoporosis model.
Ardawi MM; Badawoud MH; Hassan SM; Rouzi AA; Ardawi JMS; AlNosani NM; Qari MH; Mousa SA
Bone; 2016 Feb; 83():127-140. PubMed ID: 26549245
[TBL] [Abstract][Full Text] [Related]
48. Alteration of contraction-to-rest ratio to optimize trabecular bone adaptation induced by dynamic muscle stimulation.
Lam H; Hu M; Qin YX
Bone; 2011 Feb; 48(2):399-405. PubMed ID: 20850577
[TBL] [Abstract][Full Text] [Related]
49. [Comparison of effects of Wujia Bugu decoction) and alendronate sodium on protection the bone loss of hindlimb unloaded rats].
Fu Q; Hu SM; Yang JJ; Hao XJ; Zhu B; Wang Q; Wu ZR; Li J
Zhongguo Gu Shang; 2010 Jul; 23(7):524-8. PubMed ID: 20701129
[TBL] [Abstract][Full Text] [Related]
50. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
[TBL] [Abstract][Full Text] [Related]
51. Ursolic Acid Prevents Retinoic Acid-Induced Bone Loss in Rats.
Cheng M; Liang XH; Wang QW; Deng YT; Zhao ZX; Liu XY
Chin J Integr Med; 2019 Mar; 25(3):210-215. PubMed ID: 30159645
[TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
[TBL] [Abstract][Full Text] [Related]
53. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
[TBL] [Abstract][Full Text] [Related]
54. Simulated weightlessness-induced attenuation of testosterone production may be responsible for bone loss.
Wimalawansa SM; Wimalawansa SJ
Endocrine; 1999 Jun; 10(3):253-60. PubMed ID: 10484289
[TBL] [Abstract][Full Text] [Related]
55. Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins.
Shen Y; Li YQ; Li SP; Ma L; Ding LJ; Ji H
J Nat Med; 2010 Jul; 64(3):336-45. PubMed ID: 20376572
[TBL] [Abstract][Full Text] [Related]
56. Treatment of hydrogen molecule abates oxidative stress and alleviates bone loss induced by modeled microgravity in rats.
Sun Y; Shuang F; Chen DM; Zhou RB
Osteoporos Int; 2013 Mar; 24(3):969-78. PubMed ID: 22648000
[TBL] [Abstract][Full Text] [Related]
57. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
Tan W; Sun J; Zhou L; Li Y; Wu X
J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
[TBL] [Abstract][Full Text] [Related]
58. Quantitative computed tomographic assessment of bone mineral density changes associated with administration of prednisolone or prednisolone and alendronate sodium in dogs.
Park S; Oh J; Son KY; Cho KO; Choi J
Am J Vet Res; 2015 Jan; 76(1):28-34. PubMed ID: 25535658
[TBL] [Abstract][Full Text] [Related]
59. Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis.
Sheng ZF; Ma YL; Tong D; Fang DY; Liang QC; Liu LH; Zhang J; Liao EY
Ann Biomed Eng; 2012 Mar; 40(3):657-65. PubMed ID: 22237860
[TBL] [Abstract][Full Text] [Related]
60. The anti-osteoporotic effect of Yijung-tang in an ovariectomized rat model mediated by inhibition of osteoclast differentiation.
Kim T; Ha H; Shim KS; Cho WK; Ma JY
J Ethnopharmacol; 2013 Mar; 146(1):83-9. PubMed ID: 23219731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
